Clinical trialNCT05194995Active, not recruitingPhase 1/PHASE2Interventional

JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation

SponsorAllist Pharmaceuticals, Inc.Enrollment48Advanced Colorectal CancerAppendiceal CancerSmall Intestinal Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Shen Lin Master of medicine
Peking University Cancer Hospital & Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Research Site01
Beijing, Beijing Municipality, China
Research Site02
Beijing, Beijing Municipality, China
Research Site12
Beijing, Beijing Municipality, China
Research Site31
Beijing, Beijing Municipality, China
Research Site13
Nanning, Guangxi, China
Research Site06
Harbin, Heilongjiang, China
Research Site05
Zhengzhou, Henan, China
Research Site07
Zhengzhou, Henan, China
Research Site18
Wuhan, Hubei, China
Research Site11
Changsha, Hunan, China
Research Site29
Changsha, Hunan, China
Research Site09
Nanjing, Jiangsu, China
Research Site08
Nanchang, Jiangxi, China
Research Site16
Linyi, Shandong, China
Research Site28
Shanghai, Shanghai Municipality, China
Research Site23
Xi’an, Shanxi, China
Research Site19
Hangzhou, Zhejiang, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Feb 2022
Primary completion: 30 Apr 2025
Completion: 31 Dec 2026
Last update posted: 16 Mar 2026
Registered enrollment: 48
Registry id: NCT05194995

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.